Type 1 Diabetes clinical trials
210 active trials name this condition (recorded in the registry as “Type 1 Diabetes Mellitus”) . Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Integrating New Skills Into Diabetes Education With CGM
- SGLT2i, Pioglitazone, and Ketone Production in T1D
- Type 1 Diabetes Adolescents for Healthier Lifestyles Study
- Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
- INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
- Breakthrough - T1DM and Chronic Kidney Disease
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- CBTi for the Treatment of Insomnia in Type 1 Diabetes
- Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
- CGM Academy for Youth With Type 1 Diabetes
- Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
- EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
- Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes
- Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
- Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
- Diabetes in African Youth
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Automated Insulin for Management of Intrapartum Glycemia
- Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
- Closed Loop and Education for Hypoglycemia Awareness Restoration
- Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
- Sleep Coach for Adolescents With Type 1 Diabetes
- Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
- Family Intervention for Black Teens With Type 1 Diabetes
- Adapting Single Sessions Interventions for Type 1 Diabetes
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Restoration of Hypoglycemia Awareness With Metoclopramide
- A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
- A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)
- Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
- To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
- Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
- Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems
- Islet Transplantation in Type 1 Diabetic Kidney Allograft
- Type 1 Diabetes REst for Metabolic Health
- Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
- Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
- Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
- A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Type 1 Diabetes Mellitus” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.